Relay Therapeutics, Inc.

General ticker "RLAY" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $758.0M (TTM average)

Relay Therapeutics, Inc. follows the US Stock Market performance with the rate: 0.9%.

Estimated limits based on current volatility of 5.8%: low 2.86$, high 3.21$

Factors to consider:

  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.32$, 6.63$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.90$, 5.41$]

Financial Metrics affecting the RLAY estimates:

  • Negative: Non-GAAP EPS, $ of -2.39 <= 0.04
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -27.78 <= 1.79
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Industry operating income (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term RLAY quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-121.822.22.42.62.833.23.4
Price $

Long-term RLAY plot with estimates

246810121416Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
RLAYS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $1.38MM $25.55MM $10.01MM
Operating Expenses $300.66MM $398.55MM $382.48MM
Operating Income $-299.27MM $-373.00MM $-372.47MM
Non-Operating Income $8.77MM $31.03MM $34.76MM
R&D Expense $246.35MM $330.02MM $319.09MM
Income(Loss) $-290.51MM $-341.97MM $-337.71MM
Profit(Loss)* $-254.26MM $-341.97MM $-337.71MM
Stockholders Equity $950.22MM $752.00MM $777.79MM
Inventory $12.11MM $0.00MM $0.00MM
Assets $1,099.77MM $843.98MM $871.30MM
Operating Cash Flow $-229.49MM $-300.32MM $-249.11MM
Capital expenditure $9.06MM $4.13MM $2.02MM
Investing Cash Flow $-188.75MM $257.63MM $-41.08MM
Financing Cash Flow $289.91MM $34.75MM $270.15MM
Earnings Per Share** $-2.27 $-2.79 $-2.36

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.